RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
FDA Approves Tecentriq Immunotherapy for Specific Type of Advanced Lung Cancer. The U.S. Food and Drug Administration (FDA) approved Genentechâs Tecentriq (atezolizumab) as a treatment for people with metastatic non-small cell lung cancer (NSCLC).
Full prescribing information is available, including clinical trial information, safety, dosing, drug-drug interactions. On March 25, 2011, the U. S. Food and Drug Administration (FDA) approved ipilimumab injection (Yervoy, made by Bristol-Myers Squibb Company) for the treatment of unresectable or metastatic melanoma.